United States Holding Companies

POINT Biopharma Global Inc (PNT)

Track

Ticker: PNT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for POINT Biopharma Global Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 18 Dec 2023
Value US$1,843,999.75 | Price 105.32 | Shares 34,724 (+6.7%)
Sale 18 Dec 2023
Value US$2,056,043.76 | Price 460.24 | Shares 2,187 (+49.6%)
Sale 18 Dec 2023
Value US$111,729,350.25 | Price 12.45 | Shares 8,974,245 (-100.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-20 2023-12-18 S Sale
4.0
BVF PARTNERS L P/IL
34,724 +6.7%
105.32
US$1,844,000 		34,724 +6.7% 105.32 US$1,844,000
2023-12-20 2023-12-18 S Sale
4.0
BVF PARTNERS L P/IL
2,187 +49.6%
460.24
US$2,056,044 		2,187 +49.6% 460.24 US$2,056,044
2023-12-20 2023-12-18 S Sale
4.0
BVF PARTNERS L P/IL
62,857 +1.9%
188.40
US$2,971,688 		62,857 +1.9% 188.40 US$2,971,688
2022-11-30 2022-11-29 B Purchase
3.0
MCCANN JOE A.

Chief Executive Officer

Executive Director
2,160 +0.1%
6.64
US$14,342 		2,160 +0.1% 6.64 US$14,342
2022-11-28 2022-11-28 B Purchase
2.9
Malik Rajesh
Non-Executive Director
3,700 +inf%
6.66
US$24,642 		3,700 +inf% 6.66 US$24,642
2022-11-28 2022-11-25 B Purchase
2.2
HOGUE GERALD L.
Non-Executive Director
3,660 +inf%
6.82
US$24,943 		3,660 +inf% 6.82 US$24,943
2022-11-28 2022-11-23 B Purchase
2.2
Lubner David Charles
Non-Executive Director
3,600 +inf%
6.85
US$24,660 		3,600 +inf% 6.85 US$24,660
2022-11-23 2022-11-21 B Purchase
2.9
MARGOLIN YAEL
Non-Executive Director
1,710 +inf%
6.56
US$11,218 		1,710 +inf% 6.56 US$11,218
2022-11-21 2022-11-18 B Purchase
3.2
SILBER ALLAN C

Executive Chairman

Executive Director Large shareholder
22,397 +0.5%
6.50
US$145,580 		22,397 +0.5% 6.50 US$145,580
2022-11-21 2022-11-18 B Purchase
3.0
GOODMAN JONATHAN R.
Non-Executive Director
6,000 +16.7%
6.33
US$37,980 		6,000 +16.7% 6.33 US$37,980
2022-11-21 2022-11-17 B Purchase
3.2
SILBER ALLAN C

Executive Chairman

Executive Director Large shareholder
27,603 +0.7%
6.00
US$165,618 		27,603 +0.7% 6.00 US$165,618
2022-05-26 2022-05-25 S Sale
1.4
FLESHNER NEIL E.

Chief Medical Officer

Executive Director
564,204 -15.7%
7.51
US$4,237,172 		564,204 -15.7% 7.51 US$4,237,172
Explore more

More insider trading research around POINT Biopharma Global Inc

More insider trades in United States
Similar Financials companies with insider activity
More Holding Companies companies with insider activity
More Holding Companies companies with insider activity
Insider trading in North America